News in other languages: 1CM Inc.

04-15	Ucrania aborda el cargamento de cereales rusos "robados" en una conversación telefónica con Israel
21-10-21	Leviathan Natural Products : Israël envisage de construire un nouveau gazoduc vers l'Egypte

More news

Managers and Directors: 1CM Inc.

Manager	Title	Age	Since
Tanvi Bhandari CEO	Chief Executive Officer	-	2022-03-06
Antony Pramoth DFI	Director of Finance/CFO	-	2026-01-06

Director	Title	Age	Since
Tanvi Bhandari BRD	Director/Board Member	-	2022-03-06
Rupalee Mehta BRD	Director/Board Member	-	2022-03-06
Lucas Leone BRD	Director/Board Member	-	2022-03-06

More insiders

1CM Inc. is a Canada-based cannabis company, which is focused on cannabis and other complementary and substitutable retail industries including liquor, tobacco, and nicotine. It's One Cannabis Market is a technology platform that provides business-to-business (B2B) and business-to- consumer (B2C) Solutions, including Last Mile Delivery, Digital Signage, Big Data Analytics & Wholesale Clearing Services. Its Cost Cannabis is a brand for the urban cannabis consumer. Its Costcan Liquor includes a range of spirits, wines, beers, and other alcoholic products, expertly sourced to cater to diverse tastes and preferences. The Company is focused on expanding its operations through organic growth and by way of merger and acquisition transactions.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
26-08-12	$0.1450	+3.57%	4,000
26-08-11	$0.1400	-6.67%	3,500
26-08-07	$0.1500	+36.36%	22,500

Delayed Quote Canadian Securities Exchange

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Canadian Securities Exchange 10:38:27 2026-08-12 EDT			5-day change	1st Jan Change
0.1450 ^CAD	0.00%		+31.82%	-25.64%

07-31	1CM Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2026	CI
04-29	1CM Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2026	CI

Market Cap	17.07M 12.26M 10.63M 9.96M 9.08M 1.17B 17.33M 117M 45.77M 586M 46.05M 45.05M 1.95B	P/E 2024	57.3x	P/E 2025	57.1x
Enterprise Value	14.34M 10.3M 8.93M 8.36M 7.63M 983M 14.56M 98.38M 38.45M 492M 38.69M 37.85M 1.64B	EV / Sales 2024	0.67x	EV / Sales 2025	0.34x
Free-Float	87.24%	Yield 2024 *	-	Yield 2025	-

07-31	1CM Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2026	CI
04-29	1CM Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2026	CI
01-30	1CM Inc. Reports Earnings Results for the First Quarter Ended November 30, 2025	CI
01-07	1CM Inc. Announces Chief Financial Officer Changes, Effective January 7, 2026	CI
01-07	SNDL Acquires Five Cannabis Outlets From 1CM in Alberta and Saskatchewan	MT
12-29	1CM Inc. Reports Earnings Results for the Full Year Ended August 31, 2025	CI
12-29	1CM Inc. Auditor Raises 'Going Concern' Doubt	CI
25-07-31	1CM Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2025	CI
25-04-29	1CM Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2025	CI
25-04-09	SNDL Entering Agreement to Buy Cost Cannabis and T Cannabis Locations from 1CM	MT
25-04-08	SNDL Inc. entered into an arrangement agreement to acquire 32 cannabis retail stores from 1CM Inc. for CAD 32.2 million.	CI
25-01-29	1CM Inc. Reports Earnings Results for the First Quarter Ended November 30, 2024	CI
24-12-30	1CM Inc. Reports Earnings Results for the Full Year Ended August 31, 2024	CI

05-27	1CM Provides Update on Arrangement Agreement with SNDL	NE
01-07	1CM Announces CFO Change	NE
12-15	SNDL & 1CM Provide Update Regarding Arrangement	NE
25-06-18	1CM Receives Court Approval for Arrangement with SNDL Inc	NE
25-06-16	1CM Announces Results of Shareholder Meeting	NE

1CM Inc. Stock

Stocks

EPIC

CA68237A1093

Pharmaceuticals

Valuation: 1CM Inc.

Chart: 1CM Inc.

Latest news : 1CM Inc.

Press Releases: 1CM Inc.

News in other languages: 1CM Inc.

Quotes and Performance

Course Extremes

Managers and Directors: 1CM Inc.

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	+31.82%
Current month	+31.82%
1 month	+38.10%
3 months	+3.57%
6 months	+7.41%
Current year	-25.64%

1 week	0.11	0.15
1 month	0.1	0.15
Current year	0.08	0.2
1 year	0.08	0.5
3 years	0.08	2.5
5 years	0.08	2.5
10 years	0	2.5

Date	Insider	Type	Main position	Quantity	% Market Cap.
12/18/25	Harshil Chovatiya	Buy	Chief Financial Officer	37,000	0.0314%
12/11/25	Harshil Chovatiya	Buy	Chief Financial Officer	44,500	0.0378%
12/11/25	Harshil Chovatiya	Buy	Chief Financial Officer	5,000	0.0042%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
1CM INC.	0.00%	+31.82%	-46.30%	-92.33%	12.26M
ELI LILLY AND COMPANY	+0.43%	+4.31%	+90.84%	+130.99%	1,088B
JOHNSON & JOHNSON	+0.41%	+1.27%	+50.98%	+50.05%	629B
ABBVIE INC.	-0.53%	+1.04%	+25.23%	+63.46%	440B
ROCHE HOLDING AG	-0.92%	+0.22%	+48.34%	+37.85%	359B
NOVARTIS AG	-1.32%	-0.21%	+29.07%	+36.81%	291B
ASTRAZENECA PLC	-1.20%	-2.78%	+5.56%	+6.09%	245B
AMGEN INC.	+0.45%	+2.05%	+46.04%	+58.54%	225B
NOVO NORDISK A/S	-2.51%	+1.77%	-6.55%	-51.74%	204B
GILEAD SCIENCES, INC.	+0.07%	+3.12%	+13.21%	+69.84%	168B
Average	-0.51%	+1.37%	+25.64%	+30.96%	364.92B
Weighted average by Cap.	-0.25%	+2.20%	+49.43%	+66.32%

	2024	2025
Net sales	57.22M 41.11M 35.62M 33.37M 30.44M 3.92B 58.1M 392M 153M 1.96B 154M 151M 6.55B	73.37M 52.71M 45.67M 42.79M 39.03M 5.03B 74.5M 503M 197M 2.52B 198M 194M 8.39B
Net income	616K 442K 383K 359K 328K 42.2M 625K 4.22M 1.65M 21.13M 1.66M 1.63M 70.46M	485K 348K 302K 283K 258K 33.22M 492K 3.33M 1.3M 16.63M 1.31M 1.28M 55.47M
Net Debt	2.88M 2.07M 1.79M 1.68M 1.53M 197M 2.92M 19.74M 7.71M 98.72M 7.76M 7.59M 329M	-2.73M -1.96M -1.7M -1.59M -1.45M -187M -2.77M -18.72M -7.32M -93.62M -7.36M -7.2M -312M